{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T16:34:34Z","timestamp":1780072474447,"version":"3.54.0"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T00:00:00Z","timestamp":1400025600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0096810","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T20:27:44Z","timestamp":1400099264000},"page":"e96810","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Quality of Antimalarial Drugs and Antibiotics in Papua New Guinea: A Survey of the Health Facility Supply Chain"],"prefix":"10.1371","volume":"9","author":[{"given":"Manuel W.","family":"Hetzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Page-Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Bala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Pulford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inoni","family":"Betuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M. E.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn K.","family":"Lavu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,5,14]]},"reference":[{"key":"ref1","unstructured":"World Health Organization (2010) Guidelines for the treatment of Malaria. Geneva: World Health Organization."},{"key":"ref2","unstructured":"World Health Organization (2012) T3: Test. Treat. Track. Scaling up diagnostic testing, treatment and surveillance for malaria. Geneva: World Health Organization."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S1473-3099(12)70064-6","article-title":"Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa","volume":"12","author":"GM Nayyar","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/1475-2875-10-352","article-title":"Poor quality vital anti-malarials in Africa - an urgent neglected public health priority","volume":"10","author":"PN Newton","year":"2011","journal-title":"Malar J"},{"key":"ref5","unstructured":"Maponga C, Ondari C (2003) The quality of antimalarials: a study in selected African countries. Geneva World Health Organization."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1475-2875-11-203","article-title":"Quality of anti-malarials collected in the private and informal sectors in Guyana and Suriname","volume":"11","author":"L Evans 3rd","year":"2012","journal-title":"Malar J"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e002923","DOI":"10.1136\/bmjopen-2013-002923","article-title":"Substandard and counterfeit medicines: a systematic review of the literature","volume":"3","author":"T Almuzaini","year":"2013","journal-title":"BMJ Open"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1473-3099(06)70581-3","article-title":"Counterfeit anti-infective drugs","volume":"6","author":"PN Newton","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"308","DOI":"10.5588\/ijtld.12.0355","article-title":"Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis","volume":"17","author":"R Bate","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1039\/C0AN00627K","article-title":"Poor quality drugs: grand challenges in high throughput detection, countrywide sampling, and forensics in developing countries","volume":"136","author":"FM Fernandez","year":"2011","journal-title":"Analyst"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e7381","DOI":"10.1136\/bmj.e7381","article-title":"How to achieve international action on falsified and substandard medicines","volume":"345","author":"A Attaran","year":"2012","journal-title":"BMJ"},{"key":"ref12","unstructured":"World Health Organization (2010) Medicines: counterfeit medicines. Fact sheet No. 275. Geneva: World Health Organization. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/mediacentre\/factsheets\/fs275\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/mediacentre\/factsheets\/fs275\/en\/<\/ext-link>."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.tips.2009.11.005","article-title":"Impact of poor-quality medicines in the \u2018developing\u2019 world","volume":"31","author":"PN Newton","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"ref14","unstructured":"Faucon B, Murphy C, Whalen J (2013) Africa\u2019s Malaria Battle: Fake Drug Pipeline Undercuts Progress. The Wall Street Journal. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/online.wsj.com\/article\/SB10001424127887324474004578444942841728204.html\" xlink:type=\"simple\">http:\/\/online.wsj.com\/article\/SB10001424127887324474004578444942841728204.html<\/ext-link>."},{"key":"ref15","unstructured":"World Health Organization (2006) Counterfeit medicines. Geneva: World Health Organization. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/medicines\/services\/counterfeit\/impact\/ImpactF_S\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/medicines\/services\/counterfeit\/impact\/ImpactF_S\/en\/<\/ext-link>. Accessed: 12 August 2013."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0140-6736(12)60649-7","article-title":"Travel and fake artesunate: a risky business","volume":"380","author":"CJ Chaccour","year":"2012","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1371\/journal.pmed.1000052","article-title":"Guidelines for field surveys of the quality of medicines: a proposal","volume":"6","author":"PN Newton","year":"2009","journal-title":"PLoS Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1001\/jama.2013.3048","article-title":"Stemming the global trade in falsified and substandard medicines","volume":"309","author":"LO Gostin","year":"2013","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/1475-2875-8-253","article-title":"Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance","volume":"8","author":"NJ White","year":"2009","journal-title":"Malar J"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.actatropica.2011.08.002","article-title":"Research challenges and gaps in malaria knowledge in Papua New Guinea","volume":"121","author":"JW Kazura","year":"2011","journal-title":"Acta Trop"},{"key":"ref21","unstructured":"Papua New Guinea Department of Health (2009) National Malaria Treatment Protocol. Port Moresby: Department of Health."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/1475-2875-12-433","article-title":"Malaria case management in Papua New Guinea following the introduction of a revised treatment protocol","volume":"12","author":"J Pulford","year":"2013","journal-title":"Malar J"},{"key":"ref23","unstructured":"World Health Organization and Papua New Guinea Department of Health (2012) Health Services Delivery Profile Papua New Guinea. Port Moresby: Department of Health."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/1475-2875-9-268","article-title":"Seeking treatment for symptomatic malaria in Papua New Guinea","volume":"9","author":"CP Davy","year":"2010","journal-title":"Malar J"},{"key":"ref25","unstructured":"Hetzel MW, Gideon G, Mueller I, Siba PM (2010) Papua New Guinea\/The Global Fund Round 3 Malaria Control Programme Evaluation 2008\/2009: Results from Cross-Sectional Surveys and Sentinel Sites. Goroka: Papua New Guinea Institute of Medical Research."},{"key":"ref26","unstructured":"Angwin A, Hetzel MW, Mueller I, Siba PM, Pulford J (2014) A qualitative study of how affected individuals or their caregivers respond to suspected malaria infection in rural Papua New Guinea. P N G Med J 56 (in press)."},{"key":"ref27","unstructured":"Papua New Guinea Department of Health (2012) Papua New Guinea Pharmaceutical Country Profile. Waigani: Ministry of Health &amp; World Health Organization."},{"key":"ref28","unstructured":"The Global Fund (2013) Malaria Control in Papua New Guinea: Scaling up for Impact. The Global Fund. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/portfolio.theglobalfund.org\/en\/Grant\/Index\/PNG-809-G04-M\" xlink:type=\"simple\">http:\/\/portfolio.theglobalfund.org\/en\/Grant\/Index\/PNG-809-G04-M<\/ext-link>. Accessed: 24.05.2013."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1002\/jps.22691","article-title":"Are counterfeit or substandard anti-infective products the cause of treatment failure in Papua New Guinea","volume":"100","author":"A Nair","year":"2011","journal-title":"J Pharm Sci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e3403","DOI":"10.1371\/journal.pone.0003403","article-title":"A nationwide survey of the quality of antimalarials in retail outlets in Tanzania","volume":"3","author":"H Kaur","year":"2008","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1475-2875-11-157","article-title":"Malaria case management in Papua New Guinea prior to the introduction of a revised treatment protocol","volume":"11","author":"J Pulford","year":"2012","journal-title":"Malar J"},{"key":"ref32","unstructured":"Paediatric Society of Papua New Guinea (2005) Standard Treatment for the common illnesses of children in Papua New Guinea: A Manual for Nurses, Community Health Workers, Health Extension Officers and Doctors. Eighth Edition. Port Moresby: Department of Health."},{"key":"ref33","unstructured":"Papua New Guinea Department of Health (2005) Standard Treatment for Common Illnesses of Adults in Papua New Guinea: A Manual for Nurses, Community Health Workers, Health Extension Officers and Doctors. Port Moresby: Department of Health."},{"key":"ref34","unstructured":"Papua New Guinea Department of Health (2012) National Medicines Formulary. Port Moresby: Department of Health."},{"key":"ref35","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jchromb.2012.06.019","article-title":"Simultaneous determination of primaquine and carboxyprimaquine in plasma using solid phase extraction and LC-MS assay","volume":"902","author":"M Page-Sharp","year":"2012","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref36","unstructured":"World Health Organization (2013) WHO List of Prequalified Medicinal Products. Geneva: World Health Organization. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/prequal\/\" xlink:type=\"simple\">http:\/\/apps.who.int\/prequal\/<\/ext-link>. Accessed: 13 December 2013."},{"key":"ref37","first-page":"4","article-title":"Using High Performance Liquid Chromatography to Quantitate Artemether and Artesunate Anti-Malarial Tablets in the National Capital District, Papua New Guinea","volume":"7","author":"NT Hehonah","year":"2010","journal-title":"Pacific Journal of Medical Sciences"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1475-2875-10-144","article-title":"Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria","volume":"10","author":"J Achan","year":"2011","journal-title":"Malar J"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/1475-2875-11-424","article-title":"Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting","volume":"11","year":"2012","journal-title":"Malar J"},{"key":"ref40","first-page":"CD004389","article-title":"Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine","volume":"10","author":"GN Galappaththy","year":"2013","journal-title":"The Cochrane database of systematic reviews"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e1023","DOI":"10.1371\/journal.pone.0001023","article-title":"Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate","volume":"2","author":"S Shekalaghe","year":"2007","journal-title":"PLoS One"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1473-3099(12)70198-6","article-title":"Primaquine to prevent transmission of falciparum malaria","volume":"13","author":"NJ White","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"ref43","first-page":"CD008152","article-title":"Primaquine for reducing Plasmodium falciparum transmission","volume":"9","author":"PM Graves","year":"2012","journal-title":"The Cochrane database of systematic reviews"},{"key":"ref44","unstructured":"World Health Organization (2011) Global plan for artemisinin resistance containment. Geneva: Global Malaria Program, World Health Organization."},{"key":"ref45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/B978-0-12-407826-0.00004-7","article-title":"G6PD deficiency: global distribution, genetic variants and primaquine therapy","volume":"81","author":"RE Howes","year":"2013","journal-title":"Adv Parasitol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4269\/ajtmh.2009.80.188","article-title":"Methemoglobinemia and adverse events in Plasmodium vivax malaria patients associated with high doses of primaquine treatment","volume":"80","author":"J Carmona-Fonseca","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/1475-2875-11-202","article-title":"Implementation of basic quality control tests for malaria medicines in Amazon Basin countries: results for the 2005\u20132010 period","volume":"11","author":"V Pribluda","year":"2012","journal-title":"Malar J"},{"key":"ref48","first-page":"363","article-title":"The quality of antimalarial medicines in eastern Thailand: a case study along the Thai-Cambodian border","volume":"44","author":"S Phanouvong","year":"2013","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"ref49","first-page":"349","article-title":"The quality of antimalarial medicines in western Cambodia: a case study along the Thai-Cambodian border","volume":"44","author":"S Phanouvong","year":"2013","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"ref50","unstructured":"United States Pharmacopeia Drug Quality and Information Program (2007) Ensuring the Quality of Medicines in Resource-Limited Countries: An Operational Guide. Rockville, Md.: The United States Pharmacopeial Convention."},{"key":"ref51","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2710.2005.00685.x","article-title":"The quality of sulphadoxine-pyrimethamine and amodiaquine products in the Kenyan retail sector","volume":"30","author":"AA Amin","year":"2005","journal-title":"J Clin Pharm Ther"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1475-2875-8-22","article-title":"Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria","volume":"8","author":"O Onwujekwe","year":"2009","journal-title":"Malar J"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1365-3156.2004.01342.x","article-title":"Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials","volume":"9","author":"AM Dondorp","year":"2004","journal-title":"Trop Med Int Health"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e1001139","DOI":"10.1371\/journal.pmed.1001139","article-title":"The primacy of public health considerations in defining poor quality medicines","volume":"8","author":"PN Newton","year":"2011","journal-title":"PLoS Med"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1475-2875-9-157","article-title":"Anti-malarial drug quality in Lagos and Accra - a comparison of various quality assessments","volume":"9","author":"R Bate","year":"2010","journal-title":"Malar J"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1128\/AAC.00067-11","article-title":"Pharmacokinetics, pharmacodynamics, and allometric scaling of chloroquine in a murine malaria model","volume":"55","author":"BR Moore","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s00044-009-9250-4","article-title":"Simultaneous determination of pyrimethamine, sulfadoxine, mefloquine, and ibuprofen in pharmaceutical formulations by RP-HPLC","volume":"19","author":"MS Arayne","year":"2010","journal-title":"Med Chem Res"},{"key":"ref58","first-page":"415","article-title":"Development and Validation of RP- HPLC Method for Determination of Primaquine in Extended Release Tablets","volume":"27","author":"AP Cruz","year":"2008","journal-title":"Latin American Journal of Pharmacy"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jpba.2006.01.059","article-title":"Development and validation of a reversed-phase LC method for analysing potentially counterfeit antimalarial medicines","volume":"42","author":"MC Gaudiano","year":"2006","journal-title":"J Pharm Biomed Anal"},{"key":"ref60","first-page":"1037","article-title":"Development and validation of amoxicillin by RP-HPLC method in bulk drug and pharmaceutical dosage forms","volume":"3","author":"M Ahmed","year":"2011","journal-title":"International Journal of ChemTech Research"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/chromsci\/bms190","article-title":"Quantification of Doxycycline Hyclate in Tablets by HPLC-UV Method","volume":"51","author":"AC Kogawa","year":"2012","journal-title":"J Chromatogr Sci"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1134\/S1061934810050126","article-title":"A validated HPLC method for determination of artesunate in bulk and tablet formulation","volume":"65","author":"SS Ranher","year":"2010","journal-title":"Journal of Analytical Chemistry"},{"key":"ref63","first-page":"201","article-title":"Simultaneous HPLC-UV method for the estimation of artemether and lumefantrine in tablet dosage form","volume":"2","author":"R Arun","year":"2011","journal-title":"International Journal of Pharmaceutical and Biomedical Research"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1128\/AAC.05136-11","article-title":"Population pharmacokinetics of artemether, lumefantrine, and their respective metabolites in Papua New Guinean children with uncomplicated malaria","volume":"55","author":"S Salman","year":"2011","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0096810","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T13:14:18Z","timestamp":1565442858000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0096810"}},"subtitle":[],"editor":[{"given":"Joshua","family":"Yukich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,5,14]]},"references-count":64,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0096810","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,14]]}}}